Primary |
Scleritis |
10.5% |
Macular Oedema |
9.5% |
Pain |
7.4% |
Seasonal Allergy |
7.4% |
Back Pain |
5.3% |
Hiv Infection |
5.3% |
Trigger Finger |
5.3% |
Carpal Tunnel Syndrome |
4.2% |
Diabetic Retinal Oedema |
4.2% |
Epicondylitis |
4.2% |
Hypersensitivity |
4.2% |
Otitis Media |
4.2% |
Retinopathy Of Prematurity |
4.2% |
Sialoadenitis |
4.2% |
Sinusitis |
4.2% |
Alopecia Areata |
3.2% |
Choroidal Neovascularisation |
3.2% |
Endophthalmitis |
3.2% |
Iridocyclitis |
3.2% |
Keloid Scar |
3.2% |
|
Scleral Thinning |
10.8% |
Oesophageal Perforation |
8.1% |
Intraocular Pressure Increased |
6.8% |
Transmission Of An Infectious Agent Via A Medicinal Product |
6.8% |
Retinal Tear |
5.4% |
Vision Blurred |
5.4% |
Adverse Event |
4.1% |
Anaphylactic Reaction |
4.1% |
Anaphylactoid Reaction |
4.1% |
Chorioretinopathy |
4.1% |
Drug Interaction |
4.1% |
Gastrointestinal Perforation |
4.1% |
Haemarthrosis |
4.1% |
Joint Instability |
4.1% |
Lichen Striatus |
4.1% |
Tendon Rupture |
4.1% |
Throat Tightness |
4.1% |
Tinnitus |
4.1% |
Urticaria |
4.1% |
Visual Acuity Reduced |
4.1% |
|
Secondary |
Rheumatoid Arthritis |
15.4% |
Back Pain |
9.8% |
Sciatica |
8.9% |
Osteoporosis |
7.3% |
Ligament Sprain |
6.5% |
Status Asthmaticus |
6.5% |
Asthma |
5.7% |
Hepatic Function Abnormal |
4.9% |
Trigger Finger |
4.9% |
Dizziness |
3.3% |
Nasal Polyps |
3.3% |
Pain |
3.3% |
Tenosynovitis Stenosans |
3.3% |
Arthralgia |
2.4% |
Gastritis |
2.4% |
Hypersensitivity |
2.4% |
Insomnia |
2.4% |
Prophylaxis |
2.4% |
Prophylaxis Against Gastrointestinal Ulcer |
2.4% |
White Blood Cell Count Decreased |
2.4% |
|
Muscular Weakness |
13.8% |
Tendon Rupture |
13.8% |
Humerus Fracture |
10.3% |
Eczema |
6.9% |
Endophthalmitis |
6.9% |
Pregnancy On Oral Contraceptive |
6.9% |
Angioneurotic Oedema |
3.4% |
Cholestasis |
3.4% |
Face Oedema |
3.4% |
Haemarthrosis |
3.4% |
Injection Site Atrophy |
3.4% |
Intestinal Perforation |
3.4% |
Paraesthesia |
3.4% |
Rash Erythematous |
3.4% |
Retinal Vasculitis |
3.4% |
Ulcer |
3.4% |
Urticaria |
3.4% |
Urticaria Generalised |
3.4% |
|
Concomitant |
Rheumatoid Arthritis |
24.8% |
Behcet's Syndrome |
22.1% |
Product Used For Unknown Indication |
17.4% |
Prophylaxis |
9.5% |
Drug Use For Unknown Indication |
5.0% |
Antibiotic Prophylaxis |
2.9% |
Type 2 Diabetes Mellitus |
2.9% |
Macular Degeneration |
2.7% |
Osteoporosis |
2.3% |
Hypertension |
1.6% |
Glaucoma |
1.5% |
Sciatica |
1.1% |
Asthma |
1.0% |
Analgesia |
0.9% |
Constipation |
0.9% |
Back Pain |
0.7% |
Initial Insomnia |
0.7% |
Polymorphic Light Eruption |
0.7% |
Prophylaxis Against Gastrointestinal Ulcer |
0.7% |
Pain |
0.6% |
|
Herpes Zoster Disseminated |
19.4% |
Maculopathy |
15.7% |
Pulmonary Tuberculosis |
7.4% |
Asthenia |
5.6% |
Leukaemia |
5.6% |
Myocardial Infarction |
5.6% |
Tuberculosis |
5.6% |
Urinary Tract Infection |
5.6% |
Visual Impairment |
4.6% |
Vomiting |
3.7% |
Arthritis Infective |
2.8% |
Henoch-schonlein Purpura |
2.8% |
Visual Acuity Reduced |
2.8% |
Hypoglycaemia Neonatal |
1.9% |
Large Intestine Perforation |
1.9% |
Malaise |
1.9% |
Muscle Rigidity |
1.9% |
Osteonecrosis |
1.9% |
Pruritus |
1.9% |
Renal Impairment |
1.9% |
|
Interacting |
Asthma |
60.0% |
Hiv Infection |
40.0% |
|
|